Access inequity is driven by operational and bureaucratic challenges, affecting both low-income and developed nations, beyond ...

The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...

Chai Discovery secures $70 million to revolutionize AI-driven drug discovery, enhancing antibody design and accelerating breakthroughs in medicine.

The company is streamlining its global workforce as part of a multi-year cost-cutting strategy, while raising its 2025 ...

Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...

XtalPi and DoveTree collaborate on a groundbreaking $6 billion drug discovery partnership, merging AI technology with ...

With AI expected to play a significant role in drug approvals, how can companies build data sets that are ready for AI?

Currax Pharmaceuticals expands its impactful campaigns, showcasing real patient stories to empower those battling obesity and food cravings across the U.S.

It’s a bad time to try to predict future pharmaceutical prices.

Celltrion's Avtozma IV gains FDA approval for treating cytokine release syndrome, enhancing treatment options for patients aged 2 and older.

Ajovy becomes the first-and-only calcitonin gene-related peptide agonist approved for pediatric patients aged six to 17 years ...

The deal brings the FDA-approved neuroblastoma therapy Danyelza (naxitamab-gqgk) to SERB Pharmaceuticals and advances its ...